KAITLIN ROSLEN: Open Payments
NPI 1659756286 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,975 in 88 payments from 13 companies in 2025. Trend: 2023 $1,854 · 2024 $497 · 2025 $1,975
Food & beverage: $1,891Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $642 |
| Madrigal Pharmaceuticals | 12 | $398 |
| Janssen Biotech, Inc. | 13 | $310 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $226 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $169 |
| Ipsen Biopharmaceuticals, Inc | 2 | $49 |
| Aimmune Therapeutics, Inc. | 3 | $46 |
| Lilly USA, LLC | 2 | $36 |
| Ardelyx, Inc. | 2 | $31 |
| GENZYME CORPORATION | 1 | $25 |
Products named: REZDIFFRA, TREMFYA, RINVOQ, SKYRIZI, XIFAXAN, ENTYVIO, LINZESS, IQIRVO.
Industry payments across MO — which companies pay providers there.
